Table of Contents
June 15, 2026; Volume 23,Issue 6
Bai, Xiaoming
- Open AccessDrug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectivesYajing Liu, Yuwei Liu, Tingting Wu, Xiaoming Bai, Shuman Wang, Luyun Zhang, Zhiwen Fu and Chen ShiCancer Biology & Medicine June 2026, 23 (6) 833-864; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0707
Bao, Ensi
- Open AccessHBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1AHongjuan You, Xing Wang, Ruyu Liu, Yuxin Wang, Huanyang Zhang, Lihong Ma, Ensi Bao, Yujie Zhong, Xiangye Liu, Delong Kong, Xiucheng Pan, Xiaocui Li, Suping Qin, Kuiyang Zheng, Chen Li, Renxian Tang and Fanyun KongCancer Biology & Medicine June 2026, 23 (6) 888-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0236
Chen, Rui
- Open AccessMetabolic regulation of tumor-associated macrophage function and immunotherapy in cancerMingyue Zhao, Rui Chen and Ping GaoCancer Biology & Medicine June 2026, 23 (6) 810-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0626
Cui, Wei
- Open AccessToward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectivesJing Yu, Maochen Li, Yuhan Zhu, Shengnan Wang, Yuzhao Jiang, Wei Cui and Lingying WuCancer Biology & Medicine June 2026, 23 (6) 788-795; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0102
Cui, Yuzhen
- Open AccessOpportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancerYuzhen Cui, Jingdong Xu, Junxu Wen, Jianfeng Peng, Jiangao Ren, Ailing Liu, Xiangjiao Meng, Zhaoqin Huang and Anwen LiuCancer Biology & Medicine June 2026, 23 (6) 865-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0589
Du, Sicheng
- Open AccessExpansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process: a preclinical study for solid tumorsYing Zhang, Sicheng Du, Rongrui Liu, Chuanhua Zhao, Juan Li, Sisi Ye, Man Zhang, Xingming Ma, Zhou He, Wenjia Zhuang, Huajun Jin and Jianming XuCancer Biology & Medicine June 2026, 23 (6) 910-924; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0441
Fu, Zhiwen
- Open AccessDrug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectivesYajing Liu, Yuwei Liu, Tingting Wu, Xiaoming Bai, Shuman Wang, Luyun Zhang, Zhiwen Fu and Chen ShiCancer Biology & Medicine June 2026, 23 (6) 833-864; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0707
Gao, Chuntao
- Open AccessSequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysisYang Liu, Dandan Wu, Xing Li, Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao and Jihui HaoCancer Biology & Medicine June 2026, 23 (6) 946-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0848
Gao, Ping
- Open AccessMetabolic regulation of tumor-associated macrophage function and immunotherapy in cancerMingyue Zhao, Rui Chen and Ping GaoCancer Biology & Medicine June 2026, 23 (6) 810-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0626
Hao, Jihui
- Open AccessSequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysisYang Liu, Dandan Wu, Xing Li, Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao and Jihui HaoCancer Biology & Medicine June 2026, 23 (6) 946-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0848
In this issue





